Full-text resources of PSJD and other databases are now available in the new Library of Science.
Visit https://bibliotekanauki.pl


Preferences help
enabled [disable] Abstract
Number of results


2013 | 8 | 2 | 237-243

Article title

Subcutaneous adipose tissue measurements and better metabolic prediction


Title variants

Languages of publication



The aim of the study was to establish the importance of an additional measurement of subcutaneous adipose tissue thickness (SAT) on a predetermined position on the waistline, and its relation to waist measurements as an improvement of metabolic prediction in equally obese subjects. One hundred and forty two consecutive patients were enrolled in the study: stratified by weight as normal (body mass index - BMI 20–25 kg/m2), overweight (BMI 25–30 kg/m2) and obese (BMI >30 kg/m2); and by fasting glucose level as normoglycemic, impaired fasting glucose (IFG), or with type 2 diabetes mellitus (T2DM). SAT was measured in relaxed expiration, 3 cm left of the umbilicus, with ultrasound. Fasting blood samples for glucose, insulin and HbAlc were taken. Waist circumference was slightly higher in the IFG (112.8 cm) and normoglycemic groups (115.62 cm), compared to T2DM (108.15 cm). The T2DM group had a lower average SAT (2.7 cm) than both the IFG group (3.4 cm, p<0.01) and the normoglycemic group (4.2cm, p=0.001). The homeostatic model of assessment for insulin resistance (HOMA IR) was the lowest in normoglycemic and the highest in IFG group. Waistline radius to SAT ratio provides better insight into the deterioration of glucose metabolism than standard anthropometric markers of abdominal obesity in equally obese patients.










Physical description


1 - 4 - 2013
23 - 1 - 2013


  • Endocrinology Clinic, Military Medical Academy, Crnotravska 17, 11000, Belgrade, Serbia
  • Centre for Poisoning Control, Military Medical Academy, Crnotravska 17, 11000, Belgrade, Serbia
  • Department of Physiology, Faculty of Medicine, University of Kragujevac, Svetozara Markovica 69, 34000, Kragujevac, Serbia
  • Department of Physiology, Faculty of Medicine, University of Kragujevac, Svetozara Markovica 69, 34000, Kragujevac, Serbia
  • Department of Cardiology, University Hospital Medical Center “Bezanijska kosa”, Faculty of Medicine, University of Belgrade, Belgrade, Serbia
  • Dept. of Biochemistry, Military Medical Academy, Crnotravska 17, 11000, Belgrade, Serbia
  • Eye Clinic, Military Medical Academy, Crnotravska 17, 11000, Belgrade, Serbia
  • Institute of Epidemiology, Military Medical Academy, Crnotravska 17, 11000, Belgrade, Serbia


  • [1] Kopelman P. G. Obesity as a medical problem. Nature 2000;404:635–643
  • [2] Mauro M., Taylor V., Sean W., Sharma A.M. Barriers to obesity treatment European Journal of Internal Medicine 19 (2008) 173–180 http://dx.doi.org/10.1016/j.ejim.2007.09.011[Crossref][WoS]
  • [3] Katzmarzyk P. T., Janseen I. The economic costs associated with physical inactivity and obesity in Canada an update. Can J Appl Physiol 2004; 29:90–115 http://dx.doi.org/10.1139/h04-008[Crossref]
  • [4] Parnez H., Kawar B., El Nahas M. Obesity and diabetes in developing world-a growing challenge N Engl J Med 2007; 356: 213–215 http://dx.doi.org/10.1056/NEJMp068177[Crossref]
  • [5] Despres J. P., Lemieux I., Bergeron J., Pibarot P., Mathieu P., Larose E., et al Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk Atheroscler Thromb Vasc Biol 2008;28: 1039–1049 http://dx.doi.org/10.1161/ATVBAHA.107.159228[WoS][Crossref]
  • [6] Garaulet M., Pérez-Llamas F., Pérez-Ayala M., Martínez P., de Medina F.S., Tebar F.J., et al. Site specific differences in the fatty acid composition of abdominal adipose tissue in an obese population from a Mediterran area:relation with dietary fatty acids, plasma lipid profile, serum insulin and central obesity Am J Clin Nut 2011; 74: 585–591
  • [7] Unger R. H. Lipid overload and overflow:metabolic trauma and metabolic syndrome Trends Endocrinol Metab. 2003; 14(9):398–403 http://dx.doi.org/10.1016/j.tem.2003.09.008[Crossref]
  • [8] Festa A., D Agostino R., Williams K., Mayer-Davis E.J., Tracy R.P., Haffner S.M. The relation of body fat mass and distribution to markers of chronic inflamation. Int J Obes 2001; 25:1407–1415 http://dx.doi.org/10.1038/sj.ijo.0801792[Crossref]
  • [9] Eizirik D.L., Cardozo A.K., Cnop M. The role of endoplasmatic reticulum stress in diabetes mellitus Endocr Rev. 2008; 29: 42–61 http://dx.doi.org/10.1210/er.2007-0015[Crossref]
  • [10] Grill V., Björklund A. Type2 diabetes-effect of compensatory over secretion as a reason for beta cell collapse. Int Jnl experimental Diab Res 2002; 153–158
  • [11] Yang X., Smith U. Adipose tissue distribution and risk of metabolic disease: does thiasolidinedioneinduced adipose tissue distribution provide a clue to an answer. Diabetologia 2007; 50: 1127–1139 http://dx.doi.org/10.1007/s00125-007-0640-1[Crossref][WoS]
  • [12] Stefan N., Kantartzis K., Machann J., Schick F., Thamer C., Rittig K., et al. Identification and caracterzation of metabolically benign obesity in humans. Arch intern Med 2008; 168: 1609–1616 http://dx.doi.org/10.1001/archinte.168.15.1609[WoS][Crossref]
  • [13] Hu H.H., Nayak S., Goran I.M. Assessment of abdominal adipose tissue and organ fat content by magnetic resonance imaging Obesity reviews 2011; 12: 504–515 http://dx.doi.org/10.1111/j.1467-789X.2010.00824.x[Crossref]
  • [14] Muler H. P., Raudies F., Unrath A., Neumann H., Ludolph A.C., Kassubek J. Quantification of human body fat tissue percentage by MRI. NMR Biomed. 2011; 24(1):17–24 http://dx.doi.org/10.1002/nbm.1549[Crossref][WoS]
  • [15] Ozenoglu A., Ugurlu S., Can G., Sarkis C., Demirel Y. Differences in the body composition and biochemistry in women grouped as normal-weight, overweight and obese according to body mass index and their relation with cardiometabolic risk. Cent Eur J Med 2010; 5(6): 724–732 http://dx.doi.org/10.2478/s11536-009-0137-z[Crossref][WoS]
  • [16] McGee D.L. Body mass index and mortality: a meta-analysis based on person-level data from twenty-six observational studies Ann Epidemiol 2005; 15:87–97 http://dx.doi.org/10.1016/j.annepidem.2004.05.012[Crossref]
  • [17] Ascaso J.F., Romero P., Real J.T., Lorente R.I., Martinez-Valls J., Carmena R. Abdominal Obesity, insuline resistance, and metabolic syndrome in a southern European population. European Journal of Internal Medicine 14 (2003) 101–106 http://dx.doi.org/10.1016/S0953-6205(03)00022-0[Crossref]
  • [18] World Health Organization. Obesity: Preventing and managing the Global epidemic. Report of a WHO Consultation on obesity. World Health Organ Tech Rep Ser. 2000; 894:i–xii, 1–253
  • [19] Lean M.E., Hans T.H., Morrison C.E. Waist circumference as a measure for indicating need for weight management Br Med J 1995;15:158–161 http://dx.doi.org/10.1136/bmj.311.6998.158[Crossref]
  • [20] Alberti K.G., Zimet P., Shaw J. The metabolic Syndrome a new worldwide definition Lancet 2005;366(9491): 1059–1062 http://dx.doi.org/10.1016/S0140-6736(05)67402-8[Crossref]
  • [21] Gary T.C. Metabolic Syndrome or Central Obesity SindromeDiabetes Care, 2006; 29(3):752
  • [22] Porter S.A., Majaro J.M., Hoffmann U., Vasan R.S., O Donel J., Fox C.S. Abdominal subcutaneous adipose tisue: a protective fat depot Diabetes Care. 2009 32(6):1068–1075 http://dx.doi.org/10.2337/dc08-2280[Crossref][WoS]
  • [23] Bagust A., Beale S. Deteriorating beta cell function in type 2 diabetes: a long term model Q J Med 2003; 96: 281–882 http://dx.doi.org/10.1093/qjmed/hcg040[Crossref]
  • [24] Graber A.J., Handelsman Y., Einhorn B., Bergman D.A., Bloomgarden Z.T., Fonseca V., et al Diagnosis and menagment of prediabetes in the continium of hyperglicemia-when do the risk of diabetes begin? A consensus statement from the american college of endocrinology and the american association of clinical endocrinologists. Endocr Pract. 2008; 14(7):933–946 [Crossref]
  • [25] Cnop M., Clark A. The long life span and low turnover of human islet beta cells estimated by mathematical modeling of lipofuscin accumulation Diabetologia 2009; 53:321–330 http://dx.doi.org/10.1007/s00125-009-1562-x[Crossref][WoS]
  • [26] Perl S., Kushner J.A., Buchholz B.A., Meeker A.K., Stein G.M., Hsieh M. Significant human beta cell turnover is limited to the first three decades of life as determent by in vivo thymidin analog incorporation and radiocarbon dating J.Clin. End. and Metabol 2010; 95(10): 234–239 http://dx.doi.org/10.1210/jc.2010-0932[Crossref]
  • [27] Brown R.J., Rother K.I. Effects of beta-cell rest on beta-cell function: a review of clinical and preclinical data. Pediatric Diabetes 2008; 9(part II):14–22 http://dx.doi.org/10.1111/j.1399-5448.2007.00272.x[WoS][Crossref]
  • [28] XU Wen, LI Yan-bing, DENG Wan-ping, HAO Yuan-tao and WENG Jian-ping Remission of hyperglycemia following intensive insulin therapy in newly diagnosed type 2 diabetic patients: a long term follow up study Chin Med J 2009; 122(21); 2554–2559.
  • [29] Li Y., Xu W., Liao Z., Yao B., Chen X., Huang Z., et al. Induction of long term glicemic control in newly diagnosed type 2 diabetic patients is associated with improvement of beta cell function; Diabetes Care 2004; 27:2597–2502 http://dx.doi.org/10.2337/diacare.27.11.2597[Crossref]
  • [30] Weng J., Li Y., Xu W., Shi L, Zhang Q., Zhu D., et al. Effect of intensive insulin therapy on beta cell function and glycemic control in patients with newly diagnosed type 2 diabetes: a multicenter randomized parallel-group trial. Lancet 2008; 371: 1753–1760 http://dx.doi.org/10.1016/S0140-6736(08)60762-X[WoS][Crossref]

Document Type

Publication order reference


YADDA identifier

JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.